[17] Gallbladder disease, including gallstones (cholelithiasis) and gallbladder inflammation (cholecystitis), has been observed with incretin-based therapies
6 Given the reduced appetite and potential for muscle loss, protein needs are generally higher for individuals on GLP-1 therapy compared to standard recommendations
69 Cooking meals in batches for easy leftovers
Metabolic Support: Improves insulin sensitivity and energy balance
Estimates range from 1560% across sources depending on measurement method and whether resistance training was involved
Prior pancreatitis, gallbladder disease, kidney problems, diabetic retinopathy, significant gastrointestinal symptoms, and use of insulin or sulfonylureas may require closer risk assessment rather than automatic exclusion